Key strategic partnership with Italian farming operators
Eko Agro Group enters into a partnership agreement with RHEAURA OP to develop Agri-Photovoltaic solutions
2 March 2023
News, press releases, statements and other media content about ESGTI.
Eko Agro Group enters into a partnership agreement with RHEAURA OP to develop Agri-Photovoltaic solutions
EAG enters preliminary agreement with RWE Renewables Italia to develop Agri-Photovoltaic sites.
BioEleSonic attends Biotechgate Digital Partnering in the sector of medtech licensing and collaboration.
Rheon Medical announces new scientific advisory board comprised of leading glaucoma experts.
ESGTI AG, together with corporate bodies of ESGTI AG and a number of individuals, have been summoned to a mediation hearing in March 2023.
Our 2022 Semi-Annual Report is now available in our download centre.
On 27th July 2022, ESGTI AG held its 2022 AGM. All resolutions were passed, including approval of the Annual Report and 2021 Financial Statements.
Eko Agro Group is invited as a key speaker for agricultural innovation and investments in the Italian region of Tuscany.
Our 2021 Annual Report is now available for viewing in our download centre.
The 2022 AGM will take place on July 27th at our registered offices.
ESGTI AG is offering an early repurchase of bonds (ISIN XS2158598354) from current bond holders.
BioEleSonic discusses their approach within the technological MedTech space
Eko Agro Group discusses their approach to tackle agricultural needs today
AltEnergis discusses solutions for the future of energy
ESGTI lists on BX Swiss on 01 October 2021.
Our 2021 Semi-Annual Report is available for download in the download centre.
ESGTI publishes prospectus for planned listing on BX Swiss on 01 October 2021.
On 30 June 2021, ESGTI AG held its 2021 AGM. All resolutions were passed, including approval of the Annual Report and 2020 Financial Statements.
Positive boost for Rhéon Medical as they receive an FDA grant focusing on development of medical devices.
© 2023 ESGTI AG. All rights reserved · Legal Notice · Privacy Policy
